Potentialities of a serological method in diagnosis of atrophic gastritis


Cite item

Full Text

Abstract

Aim. To analyse diagnostic potential of “serological gastrobiopsy" in patients with various gastroduodenal diseases. Material and methods. A total of 244 patients with gastroduodenal pathology have been examined. The diagnoses made morphologically were compared with those made by the serological method. The diagnosis of duodenal ulcer, gastric ulcer, atrophic gastritis, nonatrophic gastritis was made in 155, 31, 43 and 15 patients, respectively. The type of chronic gastritis was diagnosed by the levels of gastrin-17, pepsinogen I, pepsinogen II and antibodies to Helicobacter pylori in blood serum. The diagnoses made serologically were compared with those made morphologically. Results. The highest accuracy of a serological diagnosis of mucosal atrophy of the antral stomach was observed in gastric ulcer (80.6%) and duodenal ulcer (71.6%) in high sensitivity and low specificity. The accuracy of the diagnosis of gastric body mucosa atrophy in atrophic gastritis was 60.5%, in gastric ulcer - 51.6%, in duodenal ulcer 58.7% in high specificity and low sensitivity. Serological diagnosis of gastric atrophy was accurate in 71.7%. In weak morphological picture of gastric body atrophy false negative serological diagnosis is possible. No false positive results occurred in diagnosis of gastric body mucosal atrophy (specificity 100%). A negative correlation was found between the severity of gastric body atrophy and pepsinogen I serum level (r = -0.380), pepsinogen I to pepsinogen II in blood serum (r = -0.392). No differences were revealed in gastrin-17 levels in the serum in different atrophy severity in the antral mucosa. Conclusion. “Serological gastrobiopsy" provides satisfactory accuracy of atrophic gastritis diagnosis in gastroduodenal diseases.

About the authors

S I Pimanov

Витебский государственный медицинский университет

E V Makarenko

Витебский государственный медицинский университет

References

  1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res. 1992; 52: 6735-6740.
  2. Пиманов С. И. Эзофагит, гастрит и язвенная болезнь. М.: Мед. книга; Н. Новгород: Изд-во НГМА; 2000.
  3. Sipponen P., Harkonen М., Alanko A., Suovaniemi О. Diagnosis of atrophic gastritis from serum sample. Clin. Lab. 2002; 48: 505-515.
  4. Chun K. W. U., Too H. L. I., Dong T. Q. I. A. O. et al. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen. Chin. J. Dig. Dis. 2004; 5: 22-27.
  5. Korstanje A., den Hartog G., Biemond I. et al. Role of Helicobacter pylori and autoimmunity in serological atrophic corpus gastritis in a Dutch primary care community. Eur. J. Gastroenterol. Hepatol. 2006; 18: 911-916.
  6. Вааненен X., Ваухконен M., Хелске Т. и др. Неэндоскопическая диагностика атрофического гастрита на основании анализа крови: корреляция между результатами гистологического исследования желудка и уровнями гастрина-17 и пепсиногена I в сыворотке. Клин. перспект. гастроэнтерол., гепатол. 2003; 4: 26-32.
  7. Nardone G., Rocco A., Staibano S. et al. Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment. Pharmacol. Ther. 2005; 22: 1139-1146.
  8. Ricci C., Vakil N., Rugge M. et al. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am. J. Gastroenterol. 2004; 99: 1910-1915.
  9. Di Mario F., Moussa A. M., Caruana P. et al. “Serological biopsy" in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scand. J. Gastroenterol. 2003; 28: 1223-1227.
  10. Пюрвеева К. В., Лапина Т. Л., Ивашкин В. Т. и др. Значение сывороточных показателей пепсиногена I, пепсиногена II и гастрина-17 в диагностике атрофического гастрита. Рос. журн. гастроэнтерол., гепатол., колопроктол. 2005; 15 (3): 48-51.
  11. Pasechnikov V. D., Chukov S. Z., Kotelevets S. M. et al. Possibility of noninvasive diagnosis of gastric mucosal precancerous changes. Wld. J. Gastroenterol. 2004; 10: 3146-3150.
  12. Аруин Л. И., Григорьев П. Я., Исаков В. А., Яковенко З. П. Хронический гастрит. Амстердам; 1993.
  13. Dixon М. F., Genta R. М., Yardley J. et al. Classification and grading of gastritis. The Updated Sydney System. Am. J. Surg. Pathol. 1996; 20(10): 1161-1181.
  14. Власов В. В. Эффективность диагностических исследований. М.: Медицина; 1988.
  15. Kawai Т., Kawakami К., Kudo Т. et al. Correlation between serum pepsinogen levels and gastric mucosal histological findings before and after Helicobacter pylori eradication therapy. Dig. Endosc. 2004; 16: 122-128.
  16. Пиманов С. И., Макаренко Е. В., Воропаева А. В., Матвиенко М. Е. Динамика морфологических и функциональных характеристик слизистой оболочки желудка после эрадикации Helicobacter pylori у больных с язвами двенадцатиперстной кишки. Тер. арх. 2006; 78 (2): 26-31.
  17. Ley С., Mohar A., Guarner J. et al. Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol. Biomarkers Prev. 2001; 10: 107-112.
  18. Muller O., Kircher Т., Miller-Hermelink H. K. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type. A. Am. J. Surg. Pathol. 1987; 11: 909-917.
  19. Chuang С -H., Sheu B.S., Yang H.-B. et al. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa. J. Gastroenterol. Hepatol. 2004; 19: 988-993.
  20. Herbrink P., van Doorn L. J. Serological methods for diagnosis of Helicobacter pylori infection and monitoring of eradication therapy. Eur. J. Clin. Microbiol. Infect. Dis. 2000; 19: 164-173.
  21. Vaira D., Gatta L., Ricci C., Miglioli M. Review article: diagnosis of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2002; 16 (suppl. I): 16-23.
  22. Ekesdo R., Toth E., Fork F.-T. et al. Chronic Helicobacter pylori infection in a population in southern Sweden analysed by histopathology, immunoblot and ELISA serology. Eur. J. Gastroenterol. Hepatol. 2006; 18: 589-593.
  23. Salomaa-Rasanen A., Kosunen T. U., Manila J. et al. Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis. Clin. Diagn. Lab. Immunol. 2004; 11: 1 185-1188.
  24. Kokkola A., Kosunen T. U., Puolakkainen P. et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMSS 2003; 111: 619-624.

Copyright (c) 2008 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies